# Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia

> **NCT01025778** · PHASE2 · COMPLETED · sponsor: **Lund University Hospital** · enrollment: 7 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Clofarabine for remission induction
- **DRUG:** Etoposide for remission induction
- **DRUG:** Cyclophosphamide for remission induction
- **DRUG:** Clofarabine in conditioning before transplantation
- **DRUG:** Thiotepa in conditioning before transplantation
- **DRUG:** Melfalan in conditioning before transplantation
- **PROCEDURE:** Haploidentical transplantation of T-cell depleted graft
- **PROCEDURE:** Donor lymphocyte infusion

## Key facts

- **NCT ID:** NCT01025778
- **Lead sponsor:** Lund University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01025778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01025778, "Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01025778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*